Long-Term Assessment of Safety and Physical Function With AMG 108 in RA

A Long-Term Assessment of Safety and Physical Function With AMG 108 Subcutaneous Monthly Treatment in Subjects With Rheumatoid Arthritis

The purpose of this study is to assess long-term safety of SC AMG 108 in the treatment of RA

Inclusion Criteria:

• Only subjects eligible for and completing 24 weeks of study 20050168 will be permitted to enroll.

Exclusion Criteria:

• Subjects not eligible for or not completing 24 weeks of study 20050168 will be excluded.